Literature DB >> 20123463

Animal models of brain dysfunction in phenylketonuria.

A E Martynyuk1, F J van Spronsen, E A Van der Zee.   

Abstract

Phenylketonuria (PKU) is a metabolic disorder that results in significant brain dysfunction if untreated. Although phenylalanine restricted diets instituted at birth have clearly improved PKU outcomes, neuropsychological deficits and neurological changes still represent substantial problems. The specific mechanisms by which Phe affects the brains of individuals with PKU are yet fully determined. The use of animal models in PKU research significantly broadens the possibilities for investigating these mechanisms. This report presents an overview of findings from animal studies on the mechanisms of Phe action in the PKU brain, discussing the importance of changes in protein synthesis, transport of large neutral amino acids across the blood-brain barrier, synthesis of monoamine neurotransmitters, activity of glutamate receptors, animal behavior, and translation of animal behavioral data to patients with PKU. This report shows that great progress has been made in past years and demonstrates the importance of further animal research to understand the neuropathological mechanisms underlying brain dysfunction in PKU. A better understanding of these mechanisms will guide the development of optimal treatment strategies for PKU. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20123463     DOI: 10.1016/j.ymgme.2009.10.181

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  17 in total

Review 1.  Animal models of human genetic diseases: do they need to be faithful to be useful?

Authors:  Jean-Louis Guénet
Journal:  Mol Genet Genomics       Date:  2011-05-06       Impact factor: 3.291

2.  Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.

Authors:  Emily A Sawin; Sangita G Murali; Denise M Ney
Journal:  Mol Genet Metab       Date:  2014-02-08       Impact factor: 4.797

3.  A Multiplatform Metabolomics Approach to Characterize Plasma Levels of Phenylalanine and Tyrosine in Phenylketonuria.

Authors:  H Blasco; C Veyrat-Durebex; M Bertrand; F Patin; F Labarthe; H Henique; P Emond; C R Andres; C Antar; C Landon; L Nadal-Desbarats; F Maillot
Journal:  JIMD Rep       Date:  2016-06-15

4.  Biochemical, Metabolic, and Behavioral Characteristics of Immature Chronic Hyperphenylalanemic Rats.

Authors:  Gerald A Dienel; Nancy F Cruz
Journal:  Neurochem Res       Date:  2015-07-30       Impact factor: 3.996

5.  Processing speed and executive abilities in children with phenylketonuria.

Authors:  Alicia L Janos; Dorothy K Grange; Robert D Steiner; Desirée A White
Journal:  Neuropsychology       Date:  2012-08-06       Impact factor: 3.295

6.  Voluntary Exercise Prevents Oxidative Stress in the Brain of Phenylketonuria Mice.

Authors:  Priscila Nicolao Mazzola; Vibeke Bruinenberg; Karen Anjema; Danique van Vliet; Carlos Severo Dutra-Filho; Francjan J van Spronsen; Eddy A van der Zee
Journal:  JIMD Rep       Date:  2015-10-07

7.  In vivo catecholaminergic metabolism in the medial prefrontal cortex of ENU2 mice: an investigation of the cortical dopamine deficit in phenylketonuria.

Authors:  Tiziana Pascucci; Giacomo Giacovazzo; Diego Andolina; David Conversi; Fabio Cruciani; Simona Cabib; Stefano Puglisi-Allegra
Journal:  J Inherit Metab Dis       Date:  2012-03-24       Impact factor: 4.982

8.  5-Hydroxytryptophan during critical postnatal period improves cognitive performances and promotes dendritic spine maturation in genetic mouse model of phenylketonuria.

Authors:  Diego Andolina; David Conversi; Simona Cabib; Antonio Trabalza; Rossella Ventura; Stefano Puglisi-Allegra; Tiziana Pascucci
Journal:  Int J Neuropsychopharmacol       Date:  2010-11-01       Impact factor: 5.176

9.  Behavioral and neurochemical characterization of new mouse model of hyperphenylalaninemia.

Authors:  Tiziana Pascucci; Giacomo Giacovazzo; Diego Andolina; Alessandra Accoto; Elena Fiori; Rossella Ventura; Cristina Orsini; David Conversi; Claudia Carducci; Vincenzo Leuzzi; Stefano Puglisi-Allegra
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

10.  Altered brain protein expression profiles are associated with molecular neurological dysfunction in the PKU mouse model.

Authors:  Esther Imperlini; Stefania Orrù; Claudia Corbo; Aurora Daniele; Francesco Salvatore
Journal:  J Neurochem       Date:  2014-03-24       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.